Skip to main content
. 2010 Mar 3;5(3):e9491. doi: 10.1371/journal.pone.0009491

Figure 3. Antigen presentation by HLA-DR1+ MN from individual HIV-infected and uninfected subjects.

Figure 3

In all four panels, MN (5×104/well) were incubated with soluble antigen or peptide and T cell hybridoma (1×105/well) for 24 hrs. Viremic HIV-infected individuals with VL>1000 are High VL and VL<1000 are Low VL. A. Control MN and soluble RT, B. HIV+ MN and soluble RT, C. Combined data on soluble RT presentation, D. Control MN and peptide, E. HIV+ MN and peptide, F. Combined data on peptide presentation.